Our Take
Two separate institutional failures at a major teaching hospital, both involving patient harm and vendor steering, are now in the hands of a state-level review committee with real disciplinary power.
Why it matters
Public medical institutions control access and trust. When procurement systems fail and patient referrals are compromised, the damage extends beyond the budget line to credibility itself. This is a test of whether government oversight actually moves faster than institutional self-protection.
Do this week
Medical administrators: audit your procurement controls for high-cost drugs and your referral pathways for private vendor steering this month, before similar probes land on your desk.
Two investigations handed over after state pressure
King George Medical University (KGMU) in Lucknow submitted its formal investigation report to the state government on June 11, 2026. The probe examined two separate matters: alleged fraud in the urology department involving ₹2.5 crore in medicines, and complaints that ophthalmology patients were being directed to purchase lenses and medications from select private stores instead of using hospital facilities.
The state government initiated the inquiries after requesting detailed explanations. Deputy Chief Minister Brajesh Pathak directed the Additional Chief Secretary (Medical Education) Amit Kumar Ghosh to demand a comprehensive report from KGMU. A government-level committee was subsequently formed, comprising the secretary and director general of medical education plus special secretary Ravi Ranjan, to review the findings.
A five-member internal KGMU committee conducted the investigation by collecting statements from officials and staff, examining prescriptions, surgery records, and departmental procedures. The university submitted approximately three pages of findings along with written replies to 20 specific questions raised by the government.
Vendor steering and fictitious-patient drug claims point to systemic control gaps
The urology investigation focused on the Asadhya Yojana scheme, a state program designed to cover treatment of serious illnesses. Investigators examined whether expensive cancer drugs intended for genuine patients were instead issued in the names of fictitious individuals. This suggests both procurement mismanagement and potential financial diversion.
The ophthalmology complaint is equally damaging: patients were allegedly advised to buy lenses and medicines from outside vendors instead of using hospital stock. This is patient steering, not accidental referral. It diverts institutional revenue, inflates patient costs, and erodes trust in a public facility.
Neither failure requires sophisticated fraud. Both point to weak oversight of prescriber behavior and procurement flows that should be standard in any teaching hospital. The fact that these gaps persisted long enough to trigger a state probe suggests institutional processes either lacked teeth or were ignored by specific actors with influence.
State review committee now decides on discipline
The government-level committee will now review KGMU's findings and decide on disciplinary action. That committee has formal authority; it is not a recommendation body. Outcomes could include termination, departmental restructuring, procurement system overhaul, or criminal referral depending on what the three-page report actually documents.
The timeline remains unclear. State-level medical education committees in India typically take 4 to 12 weeks to move from review to decision, though political priority can accelerate this. KGMU's deputy chief minister-level involvement suggests this is not routine.